Tests a Korean-style Mediterranean diet and step tracking in people with early myeloma-related conditions
Tests a Korean-style Mediterranean diet and step monitoring in adults with MGUS or smoldering myeloma.
Key facts
- Who runs it
- Seoul National University Bundang Hospital
- Where
- Seongnam-si, South KoreaSee the site
- Trial code
- Registry title
- Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study
- Status
- Not yet recruiting
- People taking part
- 20 people, planned
- Started
- 30 Jan 2026
- Expected to end
- 15 Jul 2027
- Type of study
- Interventional
- Treatments tested
- KORMED Diet and Physical Activity Monitoring
- Record updated
- 21 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with MGUS or smoldering multiple myeloma who can follow a Korean-style Mediterranean diet for 12 weeks and track their daily steps with a wearable device.
- Age
- 19 to 80 years
- Sex
- All sexes can join.
- Disease stage
- MGUS or smoldering multiple myeloma (SMM). Active multiple myeloma that needs treatment is not accepted.
Main reasons for not taking part
- Active multiple myeloma that needs treatment
- Taking part in another interventional clinical trial
- Severe liver, kidney or heart disease
- Uncontrolled infection or serious medical condition
- Pregnant or breastfeeding, or planning pregnancy during the study
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Participants must meet all of the following:
- Adults aged 19 to 80 years at the time of enrollment
- Diagnosed with MGUS (Monoclonal Gammopathy of Undetermined Significance) or Smoldering Multiple Myeloma (SMM) according to standard criteria
- Able and willing to follow a Korean-style Mediterranean diet (KORMED) for 12 weeks
- Able to use a smartphone and wearable device to track daily physical activity
- Willing to attend study visits and provide blood, stool, and questionnaire data at scheduled time points
- Able to understand the study procedures and provide written informed consent
Who cannot take part
- Participants will not be eligible if they meet any of the following:; Diagnosis of active multiple myeloma requiring treatment; Current participation in another interventional clinical trial; Severe liver, kidney, or heart disease that would make the diet or study procedures unsafe; Uncontrolled infection or serious medical condition that may interfere with participation; History of major gastrointestinal surgery that prevents adherence to the diet; Pregnant or breastfeeding, or planning to become pregnant during the study period; Allergy or intolerance to key components of the KORMED diet (e.g., fish, nuts, legumes) that prevents safe participation; Any condition, in the investigator's judgment, that would make participation unsafe or limit the ability to complete the study
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 80 years old?
Where in South Korea
- Seoul National University Bundang HospitalSeongnam-si, South KoreaContact: Su Min LeeNot yet recruiting
About the trial
What the trial wants to find out
This single-arm pilot study aims to evaluate the feasibility and potential health effects of a Korean-style Mediterranean diet (KORMED) and continuous physical activity measurement in patients with monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). The study investigates whether a 12-week KORMED dietary intervention, combined with monitoring of daily step counts using a wearable device, can improve metabolic and inflammatory biomarkers, body composition, gut microbiome diversity, and quality of life.
Read full original descriptionShow less
The study seeks to answer the following primary question:
Is the KORMED diet feasible and achievable for MGUS/SMM patients, as measured by changes in K-MEDAS adherence scores over 12 weeks?
Secondary questions include:
1. Does adherence to KORMED lead to improvements in BMI, inflammatory markers (CRP, IL-6), metabolic indicators (HOMA-IR, FLI), M-protein levels, and gut microbiome diversity? 2. Is increased daily physical activity, measured by step counts, associated with favorable changes in metabolic and clinical parameters? 3. Can combined dietary and activity-based lifestyle modification provide preliminary evidence supporting delayed disease progression in precursor plasma cell disorders?
The group in the trial
- KORMED Diet and Physical Activity MonitoringTreatment being tested
Participants in this single-arm study will receive a 12-week Korean-style Mediterranean diet (KORMED) intervention designed to increase consumption of vegetables, fruits, whole grains, fish, legumes, and healthy oils while limiting refined carbohydrates and red or processed meats. Participants will also undergo continuous physical activity monitoring using a wearable device to measure daily step counts throughout the intervention and follow-up period. Nutritional counseling will be provided at scheduled visits (baseline, 6 weeks, and 12 weeks), and remote check-ins will support adherence. After the 12-week intervention, participants will be followed through 52 weeks to assess changes in diet adherence, physical activity, metabolic and inflammatory biomarkers, gut microbiome diversity, and quality-of-life outcomes.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study
- Plain-language title
- Tests a Korean-style Mediterranean diet and step tracking in people with early myeloma-related conditionsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Criteria questions
- Built from NCT07305662, who can take part
- Record updated
- 21 January 2026